Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
acetylcysteine (mucomyst) (1 trial)
anakinra (Kineret) (1 trial)
baricitinib (olumiant) (1 trial)
dexamethasone (1 trial)
dornase alfa (pulmozyme) (1 trial)
enoxaparin (lovenox) (1 trial)
hyaluronic acid (1 trial)
polyethylene glycol (1 trial)
ropivacaine (naropin) (1 trial)
tobramycin (nebcin) (1 trial)
tocilizumab (actemra) (1 trial)
tranexamic acid (cyklokapron) (1 trial)
Trials (6 total)
Trial APIs (12 total)